✦ LIBER ✦

Fluvastatin in combination with bezafibrate or ciprofibrate for the treatment of dyslipidaemia in patients with established vascular disease

✍ Scribed by J.A. Papadakis; E.S. Ganotakis; I.A. Jagroop; A.F. Winder; D.P. Mikhailidis

Book ID: 119439481
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 131 KB
Volume: 144
Category: Article
ISSN: 0021-9150
DOI: 10.1016/s0021-9150(99)80686-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Statin + fibrate combination therapy: Fl

Statin + fibrate combination therapy: Fluvastatin with bezafibrate or ciprofibrate in high risk patients with vascular disease

✍ John A Papadakis; Emanuel S Ganotakis; Indera A Jagroop; Anthony F Winder; Dimit 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Statin+fibrate combination therapy-fluva

Statin+fibrate combination therapy-fluvastatin with bezafibrate or ciprofibrate in high risk patients with vascular disease

✍ Richard Wray; D. Hemsley 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 28 KB

Treatment of mixed hyperlipidemia in cor

Treatment of mixed hyperlipidemia in coronary artery disease patients with fluvastatin and bezafibrate in monotherapy and combination

✍ P. Pauciullo; M. Mancini; M. Mariani; M. Cortellaro; R. Paoletti; the FACT study 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Frequency of creatine kinase elevation d

Frequency of creatine kinase elevation during treatment with fluvastatin in combination with fibrates (bezafibrate, fenofibrate, or gemfibrozil)

✍ Michel Farnier; Michele Bortolini; Thomas Salko; Marie-Odile Freudenreich; Jonat 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Comparison of Bezafibrate and Simvastati

Comparison of Bezafibrate and Simvastatin in the Treatment of Dyslipidaemia in Patients with NIDDM

✍ Jeck, T.; Riesen, W.F.; Keller, U. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 2 views

Fibrates and HMG CoA reductase inhibitors are commonly used in the treatment of diabetic dyslipidaemia. However, these two groups of drugs have not been compared in diabetic patients in a randomized controlled trial. Therefore, a multicentre study was performed in 73 subjects with non-insulin-depend

EFFECTS OF THE TREATMENT WITH EZETIMIBE

EFFECTS OF THE TREATMENT WITH EZETIMIBE OR FLUVASTATIN COMPARED WITH EZETIMIBE CO-ADMINISTERED WITH FLUVASTATIN IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA

✍ Moriguchi, E.H.; Vieira, J.L. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 70 KB